cloudfront

Report Detail



Other2018-2023 Global Osteosarcoma Market Report (Status and Outlook)

  • RnM2475734
  • |
  • 29 August, 2018
  • |
  • Global
  • |
  • 116 pages
  • |
  • LPI(LP Information)
  • |
  • Other

2018-2023 Global Osteosarcoma Market Report (Status and Outlook)

Table of Contents

    2018-2023 Global Osteosarcoma Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Osteosarcoma Market Size 2013-2023
        • 2.1.2 Osteosarcoma Market Size CAGR by Region
      • 2.2 Osteosarcoma Segment by Type
        • 2.2.1 Intramedullary Osteosarcoma
        • 2.2.2 Juxtacortical Osteosarcoma
        • 2.2.3 Extra-Skeletal Osteosarcoma
      • 2.3 Osteosarcoma Market Size by Type
        • 2.3.1 Global Osteosarcoma Market Size Market Share by Type (2013-2018)
        • 2.3.2 Global Osteosarcoma Market Size Growth Rate by Type (2013-2018)
      • 2.4 Osteosarcoma Segment by Application
        • 2.4.1 Hospital & Clinics
        • 2.4.2 Cancer Research Institutes
      • 2.5 Osteosarcoma Market Size by Application
        • 2.5.1 Global Osteosarcoma Market Size Market Share by Application (2013-2018)
        • 2.5.2 Global Osteosarcoma Market Size Growth Rate by Application (2013-2018)

      3 Global Osteosarcoma by Players

      • 3.1 Global Osteosarcoma Market Size Market Share by Players
        • 3.1.1 Global Osteosarcoma Market Size by Players (2016-2018)
        • 3.1.2 Global Osteosarcoma Market Size Market Share by Players (2016-2018)
      • 3.2 Global Osteosarcoma Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Osteosarcoma by Regions

      • 4.1 Osteosarcoma Market Size by Regions
      • 4.2 Americas Osteosarcoma Market Size Growth
      • 4.3 APAC Osteosarcoma Market Size Growth
      • 4.4 Europe Osteosarcoma Market Size Growth
      • 4.5 Middle East & Africa Osteosarcoma Market Size Growth

      5 Americas

      • 5.1 Americas Osteosarcoma Market Size by Countries
      • 5.2 Americas Osteosarcoma Market Size by Type
      • 5.3 Americas Osteosarcoma Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Osteosarcoma Market Size by Countries
      • 6.2 APAC Osteosarcoma Market Size by Type
      • 6.3 APAC Osteosarcoma Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Osteosarcoma by Countries
      • 7.2 Europe Osteosarcoma Market Size by Type
      • 7.3 Europe Osteosarcoma Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Osteosarcoma by Countries
      • 8.2 Middle East & Africa Osteosarcoma Market Size by Type
      • 8.3 Middle East & Africa Osteosarcoma Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Osteosarcoma Market Forecast

      • 10.1 Global Osteosarcoma Market Size Forecast (2018-2023)
      • 10.2 Global Osteosarcoma Forecast by Regions
        • 10.2.1 Global Osteosarcoma Forecast by Regions (2018-2023)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Osteosarcoma Forecast by Type
      • 10.8 Global Osteosarcoma Forecast by Application

      11 Key Players Analysis

      • 11.1 Pfizer
        • 11.1.1 Company Details
        • 11.1.2 Osteosarcoma Product Offered
        • 11.1.3 Pfizer Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
        • 11.1.4 Main Business Overview
        • 11.1.5 Pfizer News
      • 11.2 Spectrum Pharmaceuticals
        • 11.2.1 Company Details
        • 11.2.2 Osteosarcoma Product Offered
        • 11.2.3 Spectrum Pharmaceuticals Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
        • 11.2.4 Main Business Overview
        • 11.2.5 Spectrum Pharmaceuticals News
      • 11.3 Hikma Pharmaceuticals
        • 11.3.1 Company Details
        • 11.3.2 Osteosarcoma Product Offered
        • 11.3.3 Hikma Pharmaceuticals Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
        • 11.3.4 Main Business Overview
        • 11.3.5 Hikma Pharmaceuticals News
      • 11.4 Baxter
        • 11.4.1 Company Details
        • 11.4.2 Osteosarcoma Product Offered
        • 11.4.3 Baxter Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
        • 11.4.4 Main Business Overview
        • 11.4.5 Baxter News
      • 11.5 Isofol
        • 11.5.1 Company Details
        • 11.5.2 Osteosarcoma Product Offered
        • 11.5.3 Isofol Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
        • 11.5.4 Main Business Overview
        • 11.5.5 Isofol News
      • 11.6 Advaxis
        • 11.6.1 Company Details
        • 11.6.2 Osteosarcoma Product Offered
        • 11.6.3 Advaxis Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
        • 11.6.4 Main Business Overview
        • 11.6.5 Advaxis News
      • 11.7 Bellicum Pharmaceuticals
        • 11.7.1 Company Details
        • 11.7.2 Osteosarcoma Product Offered
        • 11.7.3 Bellicum Pharmaceuticals Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
        • 11.7.4 Main Business Overview
        • 11.7.5 Bellicum Pharmaceuticals News
      • 11.8 Novartis
        • 11.8.1 Company Details
        • 11.8.2 Osteosarcoma Product Offered
        • 11.8.3 Novartis Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
        • 11.8.4 Main Business Overview
        • 11.8.5 Novartis News

      12 Research Findings and Conclusion

      In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Osteosarcoma market for 2018-2023.

      An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.
      Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).
      Over the next five years, LPI(LP Information) projects that Osteosarcoma will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

      This report presents a comprehensive overview, market shares and growth opportunities of Osteosarcoma market by product type, application, key companies and key regions.

      To calculate the market size, LP Information considers value generated from the sales of the following segments:

      Segmentation by product type:
      Intramedullary Osteosarcoma
      Juxtacortical Osteosarcoma
      Segmentation by application:
      Hospital & Clinics
      Cancer Research Institutes

      We can also provide the customized separate regional or country-level reports, for the following regions:
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
      Pfizer
      Spectrum Pharmaceuticals
      Hikma Pharmaceuticals
      Baxter
      Isofol
      Advaxis
      Bellicum Pharmaceuticals
      Novartis

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Osteosarcoma market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
      To understand the structure of Osteosarcoma market by identifying its various subsegments.
      Focuses on the key global Osteosarcoma players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Osteosarcoma with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Osteosarcoma submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.




      Summary:
      Get latest Market Research Reports on Osteosarcoma. Industry analysis & Market Report on Osteosarcoma is a syndicated market report, published as 2018-2023 Global Osteosarcoma Market Report (Status and Outlook). It is complete Research Study and Industry Analysis of Osteosarcoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,660.00
      $6,990.00
      $9,320.00
      3,129.19
      4,693.79
      6,258.38
      4,288.13
      6,432.20
      8,576.26
      564,512.40
      846,768.60
      1,129,024.80
      309,020.44
      463,530.67
      618,040.89
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report